McKesson Corporation Agrees to Pay More Than $13 Million to Settle Claims That it Failed to Report Suspicious Sales of Prescription Medications

MAY 5 --WASHINGTON - McKesson Corp., one of the nation’s largest distributors of pharmaceutical drugs, has agreed to settle allegations that it violated federal reporting provisions relating to its handling of certain prescription medications regulated by the Drug Enforcement Administration (DEA). Under the agreement between the company and six U.S. Attorney’s Offices, McKesson has agreed to pay $13,250,000 in civil penalties for alleged violations of its obligations under the Controlled Substances Act. >> Full Story